Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2023. Go to the latest filing (Q3 2026)

21.2B USDQ1 2023
Total value of stock positions
21.2B USD
Positions
80
Share of the ten largest
43.1%

The ten largest positions Q1 2023

  1. Visa Inc. 7.0%▲ +13.4%
  2. McKesson Corporation 5.4%▲ +45.5%
  3. UnitedHealth Group 4.7%▲ +65.7%
  4. Elevance Health 4.7%▲ +15.1%
  5. GE Aerospace 3.9%▲ +10.8%
  6. Fortinet 3.7%▲ +66.6%
  7. Amazon 3.7%▼ −38.9%
  8. Api Group Corp 3.6%▲ +0.8%
  9. Lululemon Athletica 3.2%new
  10. Meta Platforms 3.2%▲ +35.3%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q1 2023

Positions Q1 2023 per 13F filing, 18 of 18
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 3.7% 7,628,220 787.9M USD −38.9% reduced Q2 2015 32 quarters
MSFT Microsoft 1.4% 1,047,352 302.0M USD −69.5% reduced Q2 2016 28 quarters
Catalent Inc 0.4% 1,201,210 78.9M USD −15.7% reduced Q1 2018 21 quarters
BSX Boston Scientific 0.3% 1,136,881 56.9M USD −88.1% reduced Q3 2018 19 quarters
Guardant Health Inc 0.3% 2,538,889 59.5M USD −38.2% reduced Q3 2019 15 quarters
CB Chubb Limited 3.2% 3,466,740 673.2M USD −3.2% reduced Q1 2020 13 quarters
AMP Ameriprise Financial 1.4% 941,040 288.4M USD −42.9% reduced Q1 2021 9 quarters
CRL Charles River Laboratories 0.4% 394,089 79.5M USD −23.5% reduced Q1 2021 9 quarters
Intellia Therapeutics Inc 0.3% 1,569,545 58.5M USD −22.4% reduced Q2 2021 8 quarters
Hdfc Bank Ltd 2.6% 8,285,627 552.4M USD −3.3% reduced Q3 2021 7 quarters
Biomarin Pharmaceutical Inc 1.0% 2,168,617 210.9M USD −58.9% reduced Q4 2021 6 quarters
XYZ Block, Inc. 0.8% 2,354,123 161.6M USD −47.5% reduced Q4 2021 6 quarters
MA Mastercard 1.4% 796,740 289.5M USD −53.4% reduced Q1 2022 5 quarters
Amylyx Pharmaceuticals Inc 0.4% 2,962,555 86.9M USD −36.1% reduced Q1 2022 5 quarters
Inspire Med Sys Inc 0.4% 346,576 81.1M USD −37.0% reduced Q1 2022 5 quarters
MU Micron Technology 0.8% 2,856,599 172.4M USD −65.8% reduced Q2 2022 4 quarters
Seagate Technology Hldngs Pl 1.7% 5,513,957 364.6M USD −11.0% reduced Q4 2022 2 quarters
Equitable HLDGS Inc 0.5% 3,989,446 101.3M USD −23.5% reduced Q4 2022 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 81.0M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 81.0M USD

Breakdown by sector

  • Health Care 17.7%
  • Financials 14.8%
  • Technology 11.2%
  • Industrials 10.0%
  • Consumer Discretionary 7.5%
  • Communication Services 3.2%
  • Materials 2.7%
  • Utilities 0.8%
  • Consumer Staples 0.2%
  • not in our coverage 31.8%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close